Department of Pharmacoeconomics and Pharmaceutical Administration, School of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran.
Daru. 2012 Sep 10;20(1):32. doi: 10.1186/2008-2231-20-32.
Self-Monitoring of Blood Glucose (SMBG) is considered as a key factor in management of people with diabetes which is a growing and cost demanding health problem. The purpose of this study was to investigate the effect of comprehensive patient management using structured SMBG on metabolic control as well as its cost consequence analysis.
Sixty subjects were recruited in an observational study for a period of 6 months. They were provided with the ACCU-CHEK 360° View tool to fill in the values of the 7-point blood glucose profiles in three consecutive days during the study on a monthly basis. Changes in metabolic control were assessed by HbA1c and lipid profile measurement at the beginning and at the end of the study. In addition, cost consequence analysis was done considering different level of health care professionals with or without insurance coverage. The Average Cost Effectiveness Ratio (ACER) as well as Cost saving analysis were calculated and compared.
The analysis showed significant reduction in HbA1c during the 6-month period in all subjects (P = 0.000). Furthermore, a positive effect was observed on lipid profile. The cost of endocrinologist's visit in private sector was estimated to be 265.76 USD while this figure was149.15 USD for general practitioner in public sector with insurance coverage. Total complications and mortality cost saving was 154.8 USD. The lowest ACER was calculated for intervention with general practitioner in public sector with insurance coverage.
Structured SMBG results in significant improvement of glycemic status. Moreover, it is more cost saving in public sector with insurance coverage. It seems that general practitioner visits with insurance coverage is the most affordable option for people with type 2 diabetes.
自我血糖监测(SMBG)被认为是糖尿病管理的关键因素,而糖尿病是一个不断增长且耗费巨大的健康问题。本研究旨在探讨使用结构化 SMBG 对患者进行全面管理对代谢控制的影响及其成本后果分析。
在一项为期 6 个月的观察性研究中,招募了 60 名受试者。他们使用 ACCU-CHEK 360°View 工具在研究期间每月连续三天填写七点血糖谱值。在研究开始和结束时通过测量 HbA1c 和血脂谱评估代谢控制的变化。此外,考虑了有无保险覆盖的不同级别的卫生保健专业人员,进行了成本后果分析。计算并比较了平均成本效果比(ACER)和成本节约分析。
分析显示,所有受试者在 6 个月期间的 HbA1c 均显著降低(P = 0.000)。此外,血脂谱也出现了积极的影响。私人部门内分泌医生就诊的费用估计为 265.76 美元,而公共部门有保险覆盖的全科医生的费用为 149.15 美元。总并发症和死亡率的节省成本为 154.8 美元。ACER 最低的是在公共部门有保险覆盖的情况下由全科医生进行干预。
结构化 SMBG 可显著改善血糖状况。此外,在有保险覆盖的公共部门更具成本效益。对于 2 型糖尿病患者来说,似乎有保险覆盖的全科医生就诊是最经济实惠的选择。